Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Wipro Q4 Preview: Profit may fall on margin pressures. Is buyback the only thing to cheer?
Wipro is expected to report steady revenue growth but weaker profitability in the March quarter, impacted by wage hikes, acquisition-related costs and subdued discretionary spending. Sequential growth remains muted despite acquisition support, while BFSI shows resilience, and healthcare remains weak. Investors will closely track margins, deal pipeline and AI outlook.
US market outlook stable; India to gain from supply chain shift: Oppenheimer Asset Management
John Stoltzfus, MD and Chief Investment Strategist, Oppenheimer Asset Management, said that over the medium term, diversification of global supply chains and sectoral strengths in technology, healthcare, and manufacturing are expected to support growth across regions, including a potential recovery in India’s relative performance.
KKR-backed Baby Memorial to acquire 60% stake in Star Hospitals for ₹1,800 crore
Baby Memorial Hospital will acquire around 60% stake in the Hyderabad hospital chain's parent company, Unimed Healthcare.
Jhunjhunwalas-backed IKS healthcare looks to acquire TruBridge for $600 million
Nasdaq-listed company will be largest buyout for tech company till date. Will give boost for revenue cycle management offerings.
Pharma and healthcare companies to face continued margin pressure: HDFC Securities
The Indian pharmaceutical and healthcare sector is expected to see moderate revenue growth, with EBITDA margins remaining flat, in the March quarter, according to a brokerage report by HDFC Securities. "We project sales/EBITDA growth of 11%/6% YoY for our coverage universe," the brokerage added.
BofA cuts Definitive Healthcare stock price target on weak guidance By Investing.com - Investing.com India
BofA cuts Definitive Healthcare stock price target on weak guidance By Investing.comInvesting.com India
What stock market values more? Nithin Kamath of Zerodha flags a paradox investors can’t ignore
Zerodha's Nithin Kamath raises concerns about market valuations, noting that financial firms often outpace essential healthcare providers like Narayana Hospitals. He emphasizes the oddity of valuing businesses closer to profit more highly than those providing critical life-saving services.
Max Healthcare to acquire controlling stake in Kalinga Hospital for ₹300 crore
Max Healthcare to buy 58.4% of Kalinga Hospital for ₹300 crore, entering Bhubaneswar, will fund via external borrowings and lend ₹100 crore for upgrades
IHH Healthcare aims to hike its stake in Fortis to 50%: CEO Prem Kumar Nair
IHH Healthcare sees India as a major growth market. The company plans to increase its stake in Fortis Healthcare. IHH aims to expand its hospital bed count to 10,000 by 2030. Investments will focus on existing Fortis locations and integrating Gleneagles facilities. The group is also repositioning its diagnostics arm.
Stock Jumps 6% from Day’s Low After IHH Healthcare Plans to Increase Stake by 19% By Trade Brains - Investing.com India
Stock Jumps 6% from Day’s Low After IHH Healthcare Plans to Increase Stake by 19% By Trade BrainsInvesting.com India
Biocon rolls out two biosimilars in US market
Biocon has launched two new biosimilar medicines, Bosaya and Aukelso, in the United States. These drugs treat serious bone conditions. They are now available through specialty pharmacies and healthcare providers. The US Food and Drug Administration previously approved them. This launch expands Biocon's portfolio and aims to provide affordable treatment options for patients.
Biocon launches bone therapy biosimilars Bosaya, Aukelso in US market
Bosaya, a biosimilar to Prolia, and Aukelso, a biosimilar to Xgeva, are now available by prescription across the country through specialty pharmacies and healthcare providers, said the company.